UK markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
34.46-0.92 (-2.60%)
As of 03:29PM EDT. Market open.
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
34,814
29,429
39,143
43,836
Other short-term investments
388,784
275,523
369,107
150,586
Total cash
423,598
304,952
408,250
194,422
Net receivables
2,628
347
172
1,802
Other current assets
5,467
12,394
2,417
1,619
Total current assets
431,693
317,693
410,839
197,843
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
29,022
29,374
27,647
28,501
Accumulated depreciation
-22,385
-21,626
-21,126
-21,237
Net property, plant and equipment
6,637
7,748
6,521
7,264
Intangible assets
27,190
27,190
27,190
30,690
Other long-term assets
107
104
104
41
Total non-current assets
33,934
35,042
33,815
37,995
Total assets
465,627
352,735
444,654
235,838
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,494
3,340
1,228
1,048
Accrued liabilities
22,029
12,835
12,000
8,459
Other current liabilities
3,988
990
1,554
3,372
Total current liabilities
31,125
18,610
16,528
14,206
Non-current liabilities
Other long-term liabilities
4,403
5,333
7,354
10,121
Total non-current liabilities
5,331
7,921
8,650
12,275
Total liabilities
36,456
26,531
25,178
26,481
Stockholders' equity
Common stock
56
47
47
40
Retained earnings
-1,397,361
-1,255,932
-1,143,607
-1,073,096
Accumulated other comprehensive income
3,308
1,260
1,894
2,589
Total stockholders' equity
429,171
326,204
419,476
209,357
Total liabilities and stockholders' equity
465,627
352,735
444,654
235,838